Generic Drugs Profits Will Continue to Climb
Sales for generic drugs globally have increased 14 per cent at an annual rate, more than the single-digit growth rate at brand-name drug makers recently. With more baby boomers soon becoming eligable for the medicare prescription drug plan, and billions of dollars worth of drugs coming off patents this year and next, Generic drug companies will do very well for the next few years. Click here for the full story.
Long term risks do exist, a lack of innovation and blockbuster drugs in the current environment could spell trouble down the road. As the pipeline for blockbuster drugs going off patents slows down, companies will have to adjust their strategies.
